Related Experiment Video
Updated: Jun 27, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Lactylation Modification in Cardiometabolic Disorders: Function and Mechanism
Xu Li1,2,3,4,5, Pingdong Cai1,2,3,4,5, Xinyuan Tang1,2,3,4,5
1Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China.
Insights
Lactylation, a protein modification, is increasingly linked to cardiometabolic disorders (CMD). Understanding lactylation
Area of Science:
- Biochemistry and Molecular Biology
- Cardiovascular Research
- Metabolic Disease Research
Background:
- Cardiovascular disease (CVD) is a leading global cause of death.
- Cardiometabolic disorder (CMD) involves complex cardiovascular, endocrine, and inflammatory factors.
- Current diagnostic and treatment strategies for CMD are limited due to intricate pathology.
Purpose of the Study:
- To explore the molecular biology of lactylation.
- To elucidate the role and mechanisms of lactylation in cardiometabolic disorders.
- To provide insights for improved CMD diagnosis and treatment.
Main Methods:
- Review of existing literature on lactylation.
- Analysis of studies linking lactylation to protein function.
- Examination of research on lactylation in cardiac metabolic diseases.
Main Results:
- Lactylation is a significant post-translational modification (PTM).
- Lactylation influences protein spatial conformation and function.
- Evidence suggests a strong correlation between lactylation and cardiometabolic diseases.
Conclusions:
- Lactylation plays a critical role in the pathogenesis of cardiometabolic disorders.
- Further research into lactylation mechanisms can inform novel therapeutic approaches.
- Targeting lactylation may offer new avenues for managing CMD.
Abstract:
Cardiovascular disease (CVD) is recognized as the primary cause of mortality and morbidity on a global scale, and developing a clear treatment is an important tool for improving it. Cardiometabolic disorder (CMD) is a syndrome resulting from the combination of cardiovascular, endocrine, pro-thrombotic, and inflammatory health hazards. Due to their complex pathological mechanisms, there is a lack of effective diagnostic and treatment methods for cardiac metabolic disorders. Lactylation is a type of post-translational modification (PTM) that plays a regulatory role in various cellular physiological processes by inducing changes in the spatial conformation of proteins. Numerous studies have reported that lactylation modification plays a crucial role in post-translational modifications and is closely related to cardiac metabolic diseases. This article discusses the molecular biology of lactylation modifications and outlines the roles and mechanisms of lactylation modifications in cardiometabolic disorders, offering valuable insights for the diagnosis and treatment of such conditions.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Regulation of Metabolism
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Protein Glycosylation
Glycosylation occurs in...
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...

